EU Business News: Biofarma Gets New PE Owners; Montefarmaco Strikes Ipsen Deal; Stada Expands Production Network
Executive Summary
Round-up of the latest European consumer health market news: Private-equity firm Ardian acquires Italian supplements and cosmetics manufacturer Biofarma; Montefarmaco OTC strikes deal with Ipsen for GI lines; and Stada expands its production network with new Romania site.
You may also be interested in...
People On The Move: Appointments At Viatris, HFMA, Biofarma
A round up of the latest appointments in the health and wellness sector: Viatris names Scott Smith CEO as it prepares to exit OTC; the UK's Health Food Manufacturers' Association plans leadership change; Italy's Biofarma hires ex-Almirall CEO to lead company.
EU Business News: Orkla Acquires Healthspan, Bayer Invests Locally, Ipsen Targets Baltics
A round-up of the latest European consumer health business news: Norway's Orkla strengthens its supplements offering with acquisition of UK's Healthspan; Bayer makes investment commitment to German Consumer Health operation; and Ipsen strikes a deal to promote brands in the Baltics.
EU Business News: GSK Consumer Gets New Name, Navamedic Strikes Ipsen Deal, Enzymatica Optimistic After Tough Year
Round-up of the latest European consumer health business news: GSK reveals name for standalone consumer health business will be Haleon; Norways' Navamedic strikes a distribution deal with Ipsen for select GI OTC products; and Sweden's Enzymatica hopeful that changed consumer behaviors will help its sales rebound in 2022.